ARDSLEY ADVISORY PARTNERS LP: CVS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ARDSLEY ADVISORY PARTNERS LP on CVS, newest first. How the timeline and the estimate are built.
ARDSLEY ADVISORY PARTNERS LP held 40,000 CVS shares at 2026-06-30 per its 13F-HR filed 2026-07-13.
the latest 13F is the newest step
- period ended2026-06-3013F 40,000 sharesChange vs previous 13F -45,000 shares
0.45% of the 13F portfolio, value $4,138,000.
13F-HR 0001172661-26-002590 filed by ARDSLEY ADVISORY PARTNERS LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 85,000 sharesChange vs previous 13F 0 shares
0.93% of the 13F portfolio, value $6,104,700.
13F-HR 0001172661-26-002039 filed by ARDSLEY ADVISORY PARTNERS LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 85,000 sharesChange vs previous 13F -15,000 shares
0.86% of the 13F portfolio, value $6,745,600.
13F-HR 0001172661-26-000864 filed by ARDSLEY ADVISORY PARTNERS LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 100,000 sharesChange vs previous 13F -10,000 shares
1.16% of the 13F portfolio, value $7,539,000.
13F-HR 0001172661-25-004897 filed by ARDSLEY ADVISORY PARTNERS LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 110,000 sharesChange vs previous 13F not available
1.24% of the 13F portfolio, value $7,587,800.
13F-HR 0001172661-25-003308 filed by ARDSLEY ADVISORY PARTNERS LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).